Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.2 to v3.6.3, indicating a minor update to the page's template or metadata. This appears to be an internal version bump rather than a change to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-03T21:53:38.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2. This reflects a minor update to the page content rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-26T23:09:56.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now indicates enrollment is closed for this study, and new sections titled How to Read a Study Record, Common Questions, and How to Join a Study have been added; the Intervention/Treatment header formatting was adjusted and the revision version updated to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T16:04:56.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a newer version of the document label on the page. It reflects an update to the page's versioning rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-05T11:42:12.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The revision label has been updated from Revision: v3.5.3 to Revision: v3.5.4. This reflects a newer revision of the document in the revision history.
    Difference
    0.0%
    Check dated 2026-05-14T23:03:43.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333 was removed and Taoyuan, Taiwan, 333 was added in the Locations section, reflecting a corrected city designation for the recruitment site.
    Difference
    0.0%
    Check dated 2026-05-07T23:13:03.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.